Form 8-K - Current report:
SEC Accession No. 0001493152-24-040453
Filing Date
2024-10-08
Accepted
2024-10-08 16:48:35
Documents
13
Period of Report
2024-10-03
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38258
  Complete submission text file 0001493152-24-040453.txt   213704

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE pulm-20241003.xsd EX-101.SCH 3018
3 XBRL LABEL FILE pulm-20241003_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE pulm-20241003_pre.xml EX-101.PRE 24167
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701
Business Address 945 CONCORD STREET SUITE 1217 FRAMINGHAM MA 01701 (888) 355-4440
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

EIN.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 241360796
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)